Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 108
Filter
1.
BMC Endocr Disord ; 21(1): 170, 2021 Aug 20.
Article in English | MEDLINE | ID: mdl-34416890

ABSTRACT

BACKGROUND: The occurrence of hypomagnesemia in patients with primary hyperparathyroidism (PHPT) has been noted previously; however, the association of hypomagnesemia and severity of primary hyperparathyroidism remains unknown. The present study aimed to evaluate the association of hypomagnesemia with biochemical and clinical manifestations in patients with PHPT. METHODS: This was a retrospective study conducted at a tertiary hospital. We obtained data from 307 patients with PHPT from January 2010 through August 2020. Data on demographics, history, laboratory findings, bone densitometry findings, and clinical presentation and complications were collected and were compared in normal magnesium group vs hypomagnesemia group. RESULTS: Among the 307 patients with PHPT included in our study, 77 patients (33/102 [32.4%] males and 44/205 [21.5%] females) had hypomagnesemia. Mean hemoglobin levels in the hypomagnesemia group were significantly lower than those in the normal magnesium group in both males and females. In contrast, patients with hypomagnesemia had a higher mean serum calcium and parathyroid hormone than individuals with normal magnesium. The typical symptoms of PHPT, such as nephrolithiasis, bone pain/fractures, polyuria, or polydipsia, were more common in the hypomagnesemia group. In addition, patients with hypomagnesemia had a higher prevalence of osteoporosis, anemia, and hypercalcemic crisis. Even after adjusting for potential confounders, including age, sex, body mass index, estimated glomerular filtration rate, and parathyroid hormone levels, these associations remained essentially unchanged. CONCLUSION: Biochemical and clinical evidence indicates that patients with PHPT with hypomagnesemia have more severe hyperparathyroidism than those without hypomagnesemia. In addition, PHPT patients with hypomagnesemia had a higher prevalence of osteoporosis, anemia, and hypercalcemic crisis.


Subject(s)
Biomarkers/blood , Bone Density , Hypercalciuria/physiopathology , Hyperparathyroidism, Primary/pathology , Nephrocalcinosis/physiopathology , Osteoporosis/pathology , Renal Tubular Transport, Inborn Errors/physiopathology , Calcium/blood , Case-Control Studies , China/epidemiology , Female , Follow-Up Studies , Humans , Hypercalciuria/blood , Hyperparathyroidism, Primary/blood , Hyperparathyroidism, Primary/epidemiology , Male , Middle Aged , Nephrocalcinosis/blood , Osteoporosis/blood , Osteoporosis/etiology , Parathyroid Hormone/blood , Prognosis , Prospective Studies , Renal Tubular Transport, Inborn Errors/blood
2.
Vet J ; 275: 105718, 2021 09.
Article in English | MEDLINE | ID: mdl-34329743

ABSTRACT

Derangements in mineral metabolism are one of the main entities in chronic kidney disease-mineral and bone disorder (CKD-MBD). This is the second of a two-part review of the physiology and pathophysiology of calcium homeostasis in feline CKD-MBD. While dysregulation in calcium homeostasis is known to contribute to the development of vascular calcification in CKD, evidence characterising the relationship between serum calcium concentration and nephrocalcinosis and nephrolithiasis is limited. Recently, fibroblast growth factor 23 (FGF23) and α-Klotho have gained increased research interest and been shown to be important biomarkers for the prediction of CKD progression in human patients. However, conflicting evidence exists on their role in calcium homeostasis and vascular and soft tissue calcification. This review details the pathophysiology of calcium disorders associated with CKD-MBD and its implications on vascular and soft tissue mineralisation in human and feline patients. Further prospective studies investigating the clinical consequences of calcium disturbances in cats with CKD are warranted and this may provide additional insight into the pathophysiology of feline CKD-MBD.


Subject(s)
Calcium/metabolism , Cat Diseases/physiopathology , Chronic Kidney Disease-Mineral and Bone Disorder/veterinary , Animals , Cats , Chronic Kidney Disease-Mineral and Bone Disorder/physiopathology , Fibroblast Growth Factor-23 , Nephrocalcinosis/physiopathology , Nephrocalcinosis/veterinary , Vascular Calcification/physiopathology , Vascular Calcification/veterinary
3.
Regul Toxicol Pharmacol ; 117: 104776, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32871170

ABSTRACT

When extrapolating data from animal toxicological studies a default factor (dUF) of 100 is applied to derive a heath based guidance value. The UF takes into account the interspecies differences (ID) and the intraspecies variability (IV). When re-evaluating the safety of phosphates used as food additives nephrocalcinosis was identified as the critical endpoint. The underlying mechanism for nephrocalcinosis was attributed to the precipitation of calcium phosphate in the kidney, depending on its solubility, irrespective of the species and the population. Based on the mechanism, the volume of primary urine, for which the glomerular filtration rate (GFR) was used as a proxy, was considered to be the only parameter relevant for ID and IV. Median value of GFR in rats was 4.0 ml/min/kg bw. In humans it was 1.6 ml/min/kg bw in healthy adults and 0.9 in elderly. These values were calculated from the distribution of the GFR data from 8 studies in rats (n = 191), 16 studies in adults (n = 1540) and 5 studies in elderly (n = 2608). Multiplying the distribution of the ratio rat/healthy humans (ID) with the distribution of the ratio healthy humans/elderly human (IV) resulted in a phosphate specific factor of 4.5 (3.3-6.7) (median; 25th - 75th percentile).


Subject(s)
Calcium Phosphates/toxicity , Glomerular Filtration Rate/drug effects , Kidney/drug effects , Nephrocalcinosis/chemically induced , Animals , Calcium Phosphates/metabolism , Glomerular Filtration Rate/physiology , Humans , Kidney/metabolism , Nephrocalcinosis/metabolism , Nephrocalcinosis/physiopathology , Rats , Risk Assessment , Species Specificity
4.
Pediatr Nephrol ; 34(10): 1765-1776, 2019 10.
Article in English | MEDLINE | ID: mdl-31338588

ABSTRACT

BACKGROUND: Reduced kidney volume (KV) following prematurity is a proxy for reduced nephron number and is associated with the development of hypertension and end-stage renal disease in adults. We investigated whether extreme prematurity affects KV, function, and blood pressure in school-aged children and if nephrocalcinosis (NC) developed during the neonatal period had additional effects. METHODS: We investigated 60 children at a mean age of 7.7 years: 20 born extremely preterm (EPT < 28 weeks gestational age with NC (NC+)), 20 born EPT without NC (NC-), and 19 born as full-term infants (control). We measured KV by ultrasound, collected blood and urine samples to evaluate renal function, and measured office and 24-h ambulatory blood pressure (ABPM). RESULTS: Children born EPT had significantly smaller kidneys (EPT (NC+ NC-) vs control (estimated difference, 11.8 (CI - 21.51 to - 2.09 ml), p = 0.018) and lower but normal cystatin C-based glomerular filtration rate compared with control (estimated difference, - 10.11 (CI - 0.69 to - 19.5), p = 0.035). KV and function were not different between NC+ and NC- groups. Change in KV in relation to BSA (KV/BSA) from the neonatal period to school age showed significantly more EPT children with neonatal NC having a negative evolution of KV (p = 0.01). Blood pressure was normal and not different between the 3 groups. Fifty percent of EPT had a less than 10% day-to-night decline in ABPM. CONCLUSIONS: Kidney growth and volume is affected by EPT birth with NC being a potential aggravating factor. Circadian blood pressure regulation seems abnormal in EPT-born children.


Subject(s)
Blood Pressure/physiology , Infant, Extremely Premature/physiology , Kidney/growth & development , Nephrocalcinosis/complications , Blood Pressure Monitoring, Ambulatory/statistics & numerical data , Case-Control Studies , Child , Circadian Rhythm/physiology , Female , Follow-Up Studies , Glomerular Filtration Rate/physiology , Humans , Infant, Newborn , Kidney/diagnostic imaging , Kidney/physiopathology , Kidney Function Tests , Male , Nephrocalcinosis/blood , Nephrocalcinosis/physiopathology , Nephrocalcinosis/urine , Organ Size , Sweden , Ultrasonography
5.
Am J Physiol Renal Physiol ; 316(5): F966-F969, 2019 05 01.
Article in English | MEDLINE | ID: mdl-30838875

ABSTRACT

The proximal tubule (PT) is responsible for the majority of calcium reabsorption by the kidney. Most PT calcium transport appears to be passive, although the molecular facilitators have not been well established. Emerging evidence supports a major role for PT calcium transport in idiopathic hypercalciuria and the development of kidney stones. This review will cover recent developments in our understanding of PT calcium transport and the role of the PT in kidney stone formation.


Subject(s)
Calcium/metabolism , Hypercalciuria/complications , Kidney Calculi/etiology , Kidney Tubules, Proximal/metabolism , Membrane Transport Proteins/metabolism , Nephrocalcinosis/etiology , Renal Reabsorption , Animals , Claudins/metabolism , Humans , Hypercalciuria/metabolism , Hypercalciuria/physiopathology , Ion Transport , Kidney Calculi/metabolism , Kidney Calculi/physiopathology , Kidney Tubules, Proximal/physiopathology , Nephrocalcinosis/metabolism , Nephrocalcinosis/physiopathology
6.
Article in English | MEDLINE | ID: mdl-30901068

ABSTRACT

A 72-year-old female patient presented with an end-stage renal disease on on-line hemodiafiltration and warfarin therapy with advanced ulcerated calciphylaxis on the lower extremities, complicated by two episodes of cellulitis. She was successfully treated for 8 months with intravenous sodium thiosulfate in combination with modification of medication and dialysis treatment, careful wound care, and other supportive measures. Calciphylaxis is an uncommon life-threatening systemic disease, mostly occurring in patients with chronic kidney disease and other risk factors. Vascular calcifications and inflammation lead to thrombotic occlusions of the cutaneous and subcutaneous arterioles, which provoke livedoid painful plaques with possible progression to necrotic ulcers. Conventional treatment is supportive. In recent decades, off-label treatment with sodium thiosulfate, a potent calcium chelator, antioxidant, and vasodilator, has been increasingly reported to be highly efficient in calciphylaxis, leading to significantly lower mortality rates. Knowledge of advancement in the treatment of calciphylaxis, which was previously a highly fatal disease, is important for physicians and other professionals from various medical fields.


Subject(s)
Calciphylaxis/complications , Calciphylaxis/pathology , Kidney Failure, Chronic/drug therapy , Kidney Failure, Chronic/etiology , Nephrocalcinosis/etiology , Thiosulfates/therapeutic use , Aged , Calciphylaxis/physiopathology , Female , Follow-Up Studies , Humans , Infusions, Intravenous , Kidney Failure, Chronic/physiopathology , Leg Ulcer/etiology , Leg Ulcer/pathology , Leg Ulcer/physiopathology , Nephrocalcinosis/physiopathology , Rare Diseases , Renal Dialysis/methods , Risk Assessment , Severity of Illness Index , Slovenia , Treatment Outcome
7.
Sci Rep ; 8(1): 14157, 2018 09 21.
Article in English | MEDLINE | ID: mdl-30242165

ABSTRACT

Nephrocalcinosis often begins on a calcium phosphate deposit, at the tip of the medullo-papillary complex (MPC) known as Randall's plaque (RP). Contextualizing proximally observed biominerals within the MPC has led us to postulate a mechanobiological switch that can trigger interstitial biomineralization at the MPC tip, remote from the intratubular biominerals. Micro X-ray computed tomography scans of human MPCs correlated with transmission and scanning electron micrographs, and X-ray energy dispersive spectrometry demonstrated novel findings about anatomically-specific biominerals. An abundance of proximal intratubular biominerals were associated with emergence of distal interstitial RP. The fundamental architecture of the MPC and mineral densities at the proximal and distal locations of the MPC differed markedly. A predominance of plate-like minerals or radially oriented plate-like crystallites within spheroidal minerals in the proximal intratubular locations, and core-shell type crystallites within spheroidal minerals in distal interstitial locations were observed. Based on the MPC anatomic location of structure-specific biominerals, a biological switch within the mineral-free zone occurring between the proximal and distal locations is postulated. The "on" and "off" switch is dependent on changes in the pressure differential resulting from changes in tubule diameters; the "Venturi effect" changes the "circumferential strain" and culminates in interstitial crystal deposits in the distal tubule wall in response to proximal tubular obstruction. These distal interstitial mineralizations can emerge into the collecting system of the kidney linking nephrocalcinosis with nephrolithiasis.


Subject(s)
Biomineralization/physiology , Kidney Medulla/physiology , Calcium Phosphates/metabolism , Humans , Kidney Medulla/metabolism , Minerals/metabolism , Nephrocalcinosis/metabolism , Nephrocalcinosis/physiopathology , X-Ray Microtomography/methods
8.
Kidney Int ; 93(3): 580-588, 2018 03.
Article in English | MEDLINE | ID: mdl-29129401

ABSTRACT

The tight junction proteins claudin-10 and -16 are crucial for the paracellular reabsorption of cations along the thick ascending limb of Henle's loop in the kidney. In patients, mutations in CLDN16 cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis, while mutations in CLDN10 impair kidney function. Mice lacking claudin-16 display magnesium and calcium wasting, whereas absence of claudin-10 results in hypermagnesemia and interstitial nephrocalcinosis. In order to study the functional interdependence of claudin-10 and -16 we generated double-deficient mice. These mice had normal serum magnesium and urinary excretion of magnesium and calcium and showed polyuria and sodium retention at the expense of increased renal potassium excretion, but no nephrocalcinosis. Isolated thick ascending limb tubules of double mutants displayed a complete loss of paracellular cation selectivity and functionality. Mice lacking both claudin-10 and -16 in the thick ascending limb recruited downstream compensatory mechanisms and showed hypertrophic distal convoluted tubules with changes in gene expression and phosphorylation of ion transporters in this segment, presumably triggered by the mild decrease in serum potassium. Thus, severe individual phenotypes in claudin-10 and claudin-16 knockout mice are corrected by the additional deletion of the other claudin.


Subject(s)
Claudins/deficiency , Hypercalciuria/prevention & control , Kidney Tubules, Distal/metabolism , Loop of Henle/metabolism , Magnesium Deficiency/prevention & control , Animals , Calcium/metabolism , Claudins/genetics , Disease Models, Animal , Gene Deletion , Genetic Predisposition to Disease , Hypercalciuria/genetics , Hypercalciuria/metabolism , Hypercalciuria/physiopathology , Kidney Tubules, Distal/pathology , Kidney Tubules, Distal/physiopathology , Loop of Henle/pathology , Loop of Henle/physiopathology , Magnesium/metabolism , Magnesium Deficiency/genetics , Magnesium Deficiency/metabolism , Magnesium Deficiency/physiopathology , Mice, Inbred C57BL , Mice, Knockout , Nephrocalcinosis/genetics , Nephrocalcinosis/metabolism , Nephrocalcinosis/physiopathology , Nephrocalcinosis/prevention & control , Phenotype , Sodium/metabolism
9.
Toxicol Mech Methods ; 28(3): 195-204, 2018 Mar.
Article in English | MEDLINE | ID: mdl-28980857

ABSTRACT

Experimental induction of hyperoxaluria by ethylene glycol (EG) administration is disapproved as it causes metabolic acidosis while the oral administration of chemically synthesized potassium oxalate (KOx) diet does not mimic our natural system. Since existing models comprise limitations, this study is aimed to develop an improved model for the induction of dietary hyperoxaluria, and nephrocalcinosis in experimental rats by administration of naturally available oxalate rich diet. Male albino Wistar rats were divided into five groups. Group I, control; group II rats received 0.75% EG, group III rats fed with 5% KOx diet and group IV and V rats were administered with spinach extract of 250 and 500 mg soluble oxalate/day respectively, for 28 d. Urine and serum biochemistry were analyzed. After the experimental period, rats were sacrificed, liver and kidney tissue homogenates were used for antioxidant and lipid peroxidation assay. Relative change in expression of kidney injury molecule-1 (KIM-1) and crystal modulators genes in kidney tissues were evaluated. Tissue damage was assessed by histology studies of liver and kidney. Experimental group rats developed hyperoxaluria and crystalluria. Urine parameters, serum biochemistry, antioxidant profile, lipid peroxidation levels and gene expression analysis of experimental group II and III rats reflected acute kidney damage compared to group V rats. Histopathology results showed moderate hyperplasia in liver and severe interstitial inflammation in kidneys of group II and III than group V rats. Ingestion of naturally available oxalate enriched spinach extract successfully induced dietary hyperoxaluria and nephrocalcinosis in rats with minimal kidney damage.


Subject(s)
Disease Models, Animal , Foodborne Diseases/etiology , Hyperoxaluria/etiology , Nephrocalcinosis/etiology , Oxalic Acid/poisoning , Plant Leaves/adverse effects , Spinacia oleracea/adverse effects , Administration, Oral , Animals , Biomarkers/blood , Biomarkers/metabolism , Biomarkers/urine , Crystallization , Ethylene Glycol/toxicity , Foodborne Diseases/metabolism , Foodborne Diseases/pathology , Foodborne Diseases/physiopathology , Gene Expression Regulation/drug effects , Hyperoxaluria/metabolism , Hyperoxaluria/pathology , Hyperoxaluria/physiopathology , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/metabolism , Liver/pathology , Male , Nephrocalcinosis/metabolism , Nephrocalcinosis/pathology , Nephrocalcinosis/physiopathology , Oxalic Acid/administration & dosage , Oxalic Acid/chemistry , Oxalic Acid/metabolism , Plant Extracts/adverse effects , Plant Extracts/chemistry , Plant Leaves/chemistry , Rats, Wistar , Renal Insufficiency/etiology , Spinacia oleracea/chemistry
10.
Saudi J Kidney Dis Transpl ; 28(5): 1064-1068, 2017.
Article in English | MEDLINE | ID: mdl-28937064

ABSTRACT

Nephrocalcinosis (NC) is defined as deposition of calcium crystals in the renal parenchyma and tubules. This is a retrospective review of all the data of 63 children presented to Pediatric Nephrology Clinic at King Hussein Medical Center (KHMC) over a 15-year period with bilateral NC. We determine their causes, clinical presentation and evaluate their growth and renal function during their follow-up. Thirty-five (55.5%) cases were males and 28 (44.5%) were females. The median (range) age at presentation was four (2-192) months. The most common leading cause to NC was hereditary tubulopathy in 48% followed by hyperoxaluria in 35%. The cause of NC remained unknown in 3% and Vitamin D excess accounts for 5% of the cases. The most presenting symptom was a failure to thrive (68%) and the second most common symptom was abdominal pain and recurrent urinary tract infection was found in 40%, polyuria and polydipsia were found in 32% of cases, and 16% of cases were diagnosed incidentally. At a median follow-up of 38 (14-200) months, estimated glomerular filtration rate had decreased from 84.0 (42-110) mL/min per 1.73 m2 body surface area to 68.2 (10-110) mL/min/1.73 m2 body surface (P = 0.001). This study illustrated the need for a national registry of rare renal diseases to help understand the causes of these conditions in our populations and provide support to affected patients and their families.


Subject(s)
Nephrocalcinosis/epidemiology , Nephrocalcinosis/therapy , Abdominal Pain/epidemiology , Abdominal Pain/therapy , Adolescent , Age Factors , Child , Child, Preschool , Failure to Thrive/epidemiology , Failure to Thrive/therapy , Female , Glomerular Filtration Rate , Humans , Infant , Kidney/physiopathology , Male , Nephrocalcinosis/diagnosis , Nephrocalcinosis/physiopathology , Polydipsia/epidemiology , Polydipsia/therapy , Polyuria/epidemiology , Polyuria/therapy , Retrospective Studies , Risk Factors , Time Factors , Treatment Outcome , Urinary Tract Infections/epidemiology , Urinary Tract Infections/therapy
11.
Curr Opin Pediatr ; 29(2): 187-198, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27906866

ABSTRACT

PURPOSE OF REVIEW: Magnesium (Mg) imbalances are frequently overlooked. Hypermagnesemia usually occurs in preeclamptic women after Mg therapy or in end-stage renal disease patients, whereas hypomagnesemia is more common with a prevalence of up to 15% in the general population. Increasing evidence points toward a role for mild-to-moderate chronic hypomagnesemia in the pathogenesis of hypertension, type 2 diabetes mellitus, and metabolic syndrome. RECENT FINDINGS: The kidneys are the major regulator of total body Mg homeostasis. Over the last decade, the identification of the responsible genes in rare genetic disorders has enhanced our understanding of how the kidney handles Mg. The different genetic disorders and medications contributing to abnormal Mg homeostasis are reviewed. SUMMARY: As dysfunctional Mg homeostasis contributes to the development of many common human disorders, serum Mg deserves closer monitoring. Hypomagnesemic patients may be asymptomatic or may have mild symptoms. In severe hypomagnesemia, patients may present with neurological symptoms such as seizures, spasms, or cramps. Renal symptoms include nephrocalcinosis and impaired renal function. Most conditions affect tubular Mg reabsorption by disturbing the lumen-positive potential in the thick ascending limb or the negative membrane potential in the distal convoluted tubule.


Subject(s)
Genetic Predisposition to Disease/epidemiology , Hepatocyte Nuclear Factor 1-beta/genetics , Hypercalciuria/diagnosis , Hypercalciuria/therapy , Magnesium Deficiency/genetics , Magnesium/blood , Nephrocalcinosis/diagnosis , Nephrocalcinosis/therapy , Renal Tubular Transport, Inborn Errors/diagnosis , Renal Tubular Transport, Inborn Errors/therapy , Diagnosis, Differential , Female , Homeostasis/physiology , Humans , Hypercalciuria/genetics , Kidney/metabolism , Magnesium/metabolism , Magnesium Deficiency/blood , Male , Nephrocalcinosis/genetics , Nephrocalcinosis/physiopathology , Prognosis , Renal Tubular Transport, Inborn Errors/genetics , Risk Assessment
13.
Ren Fail ; 37(1): 180-3, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25366522

ABSTRACT

Familial hypomagnesemia with hypercalciuria and nephrocalcinosis is a rare autosomal recessive renal disease caused by mutations in genes for the tight junction transmembrane proteins Claudin-16 (CLDN16) and Claudin-19 (CLDN19). We present the first case report of a Mexican family with three affected sisters carrying a p.Gly20Asp mutation in CLDN19 whose heterozygous mother showed evident hypercalciuria and normal low magnesemia without any other clinical, laboratory, and radiological symptoms of renal disease making of her an unsuitable donor. The affected sisters showed variable phenotypic expression including age of first symptoms, renal urinary tract infections, nephrolithiasis, nephrocalcinosis, and eye symptoms consisting in retinochoroiditis, strabismus, macular scars, bilateral anisocoria, and severe myopia and astigmatism. End stage renal disease due to renal failure needed kidney transplantation in the three of them. Interesting findings were a heterozygous mother with asymptomatic hypercalciuria warning on the need of carefully explore clinical, laboratory, kidney ultrasonograpy, and mutation status in first degree asymptomatic relatives to avoid inappropriate kidney donors; an evident variable phenotypic expression among patients; the identification of a mutation almost confined to Spanish cases and a 3.5 Mb block of genomic homozygosis strongly suggesting a common remote parental ancestor for the gene mutation reported.


Subject(s)
Claudins/genetics , Hypercalciuria , Kidney Failure, Chronic , Nephrocalcinosis , Renal Tubular Transport, Inborn Errors , Adult , Female , Genetic Carrier Screening , Humans , Hypercalciuria/complications , Hypercalciuria/diagnosis , Hypercalciuria/ethnology , Hypercalciuria/genetics , Hypercalciuria/physiopathology , Kidney Failure, Chronic/etiology , Kidney Failure, Chronic/surgery , Kidney Transplantation , Mexico , Middle Aged , Mutation , Nephrocalcinosis/complications , Nephrocalcinosis/diagnosis , Nephrocalcinosis/ethnology , Nephrocalcinosis/genetics , Nephrocalcinosis/physiopathology , Pedigree , Renal Tubular Transport, Inborn Errors/complications , Renal Tubular Transport, Inborn Errors/diagnosis , Renal Tubular Transport, Inborn Errors/ethnology , Renal Tubular Transport, Inborn Errors/genetics , Renal Tubular Transport, Inborn Errors/physiopathology
14.
Am J Kidney Dis ; 65(1): 122-6, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25446019

ABSTRACT

Loss-of-function mutations of CYP24A1, the enzyme that converts the major circulating and active forms of vitamin D to inactive metabolites, recently have been implicated in idiopathic infantile hypercalcemia. Patients with biallelic mutations in CYP24A1 present with severe hypercalcemia and nephrocalcinosis in infancy or hypercalciuria, kidney stones, and nephrocalcinosis in adulthood. We describe a cohort of 7 patients (2 adults, 5 children) presenting with severe hypercalcemia who had homozygous or compound heterozygous mutations in CYP24A1. Acute episodes of hypercalcemia in infancy were the first symptom in 6 of 7 patients; in all patients, symptoms included nephrocalcinosis, hypercalciuria, low parathyroid hormone (PTH) levels, and higher than expected 1,25-dihydroxyvitamin D levels. Longitudinal data suggested that in most patients, periods of increased sunlight exposure tended to correlate with decreases in PTH levels and increases in calcemia and calciuria. Follow-up of the 2 adult patients showed reduced glomerular filtration rate and extrarenal manifestations, including calcic corneal deposits and osteoporosis. Cases of severe PTH-independent hypercalcemia associated with hypercalciuria in infants should prompt genetic analysis of CYP24A1. These patients should be monitored carefully throughout life because they may be at increased risk for developing chronic kidney disease.


Subject(s)
Diphosphonates/pharmacology , Fluid Therapy/methods , Hypercalcemia , Nephrocalcinosis , Nephrolithiasis , Sunlight/adverse effects , Vitamin D3 24-Hydroxylase/genetics , Vitamin D/analogs & derivatives , Bone Density Conservation Agents/pharmacology , Calcium/metabolism , Child , Child, Preschool , Female , Humans , Hypercalcemia/genetics , Hypercalcemia/physiopathology , Hypercalciuria/genetics , Hypercalciuria/physiopathology , Infant , Kidney Function Tests/methods , Male , Middle Aged , Monitoring, Physiologic/methods , Mutation , Nephrocalcinosis/etiology , Nephrocalcinosis/metabolism , Nephrocalcinosis/physiopathology , Nephrolithiasis/etiology , Nephrolithiasis/metabolism , Nephrolithiasis/physiopathology , Parathyroid Hormone/blood , Renal Insufficiency, Chronic/etiology , Renal Insufficiency, Chronic/prevention & control , Seasons , Treatment Outcome , Vitamin D/metabolism , Vitamin D/pharmacology , Vitamin D3 24-Hydroxylase/metabolism
15.
Pan Afr Med J ; 22: 276, 2015.
Article in English | MEDLINE | ID: mdl-26958139

ABSTRACT

Williams-Beuren syndrome is a rare neurodevelopmental disorder, characterized by congenital heart defects, abnormal facial features, mental retardation with specific cognitive and behavioral profile, growth hormone deficiency, renal and skeletal anomalies, inguinal hernia, infantile hypercalcaemia. We report a case with Williams-Beuren syndrome associated with a single kidney and nephrocalcinosis complicated by hypercalcaemia. A male infant, aged 20 months presented growth retardation associated with a psychomotor impairment, dysmorphic features and nephrocalcinosis. He had also hypercalciuria and hypercalcemia. Echocardiography was normal. DMSA renal scintigraphy showed a single functioning kidney. The FISH generated one ELN signal in 20 metaphases read and found the presence of ELN deletion, with compatible Williams-Beuren syndrome.


Subject(s)
Hypercalcemia/etiology , Kidney/abnormalities , Nephrocalcinosis/etiology , Williams Syndrome/physiopathology , Elastin/genetics , Hernia, Inguinal/etiology , Hernia, Inguinal/physiopathology , Humans , Hypercalcemia/physiopathology , Infant , Male , Nephrocalcinosis/physiopathology , Williams Syndrome/diagnosis , Williams Syndrome/genetics
16.
Curr Pediatr Rev ; 10(3): 194-7, 2014.
Article in English | MEDLINE | ID: mdl-25088339

ABSTRACT

Chvostek's Sign was first described in 1876, as a clinical clue associated with patients who suffered from latent tetany, and is induced by percussion of the angle of the jaw. However, over the years many clinicians have called into question the strength of the association with latent tetany, particularly in paediatric practice. This review examines the variation in techniques used to elicit the sign in studies conducted on this phenomenon in children as well as how differences in the classification of a positive Chvostek's sign have lead to varied reports on the strength of the association. Furthermore, an appraisal of the literature regarding the proposed mechanism of Chvostek's sign is reported alongside analysing other diseases which have been associated with Chvostek's sign to uncover any unifying mechanism for the presence of this clinical sign in children.


Subject(s)
Epilepsy/diagnosis , Facial Muscles/innervation , Facial Nerve/physiopathology , Hypercalciuria/diagnosis , Migraine Disorders/diagnosis , Nephrocalcinosis/diagnosis , Renal Tubular Transport, Inborn Errors/diagnosis , Tetany/diagnosis , Child , Child, Preschool , Epilepsy/physiopathology , History, 19th Century , History, 20th Century , History, 21st Century , Humans , Hypercalciuria/physiopathology , Infant , Migraine Disorders/physiopathology , Nephrocalcinosis/physiopathology , Physical Stimulation , Predictive Value of Tests , Renal Tubular Transport, Inborn Errors/physiopathology , Tetany/history , Tetany/physiopathology
17.
Urol Int ; 92(2): 246-9, 2014.
Article in English | MEDLINE | ID: mdl-23860485

ABSTRACT

Distal renal tubular acidosis combined with medullary sponge kidney (MSK) is not uncommon in adults, but is rare in infants. We report a 13-month-old boy with MSK who had features of distal renal tubular acidosis (nephrocalcinosis, hypercalciuria, hypocitraturia) and failed to thrive. Renal ultrasound revealed bilateral increased medullary echogenicity and nephrocalcinosis. Bilateral medullary nephrocalcinosis in the ultrasound was the first sign that alerted our pediatrician to the presence of MSK in infants. Earlier treatment may increase efficacy.


Subject(s)
Acidosis, Renal Tubular/congenital , Acidosis, Renal Tubular/complications , Medullary Sponge Kidney/complications , Humans , Infant , Kidney/diagnostic imaging , Magnetic Resonance Imaging , Male , Nephrocalcinosis/physiopathology , Potassium Citrate/administration & dosage , Ultrasonography , Urography
18.
Turk J Pediatr ; 55(1): 58-62, 2013.
Article in English | MEDLINE | ID: mdl-23692833

ABSTRACT

The aim of this study was to analyze the etiology of nephrocalcinosis (NC) and whether it has any effect on growth and renal function in children. Forty-three children who were diagnosed with bilateral NC were studied retrospectively. Two neonates treated with furosemide and five premature infants were excluded from the study. The most common condition leading to NC was hereditary tubulopathies (50%). Data of 27 children who had a follow-up period of at least two years were examined in more detail. Of the 27 patients, the median age at first examination was 12 (range: 2-132) months and median follow-up time was 57 (range: 24-209) months. Thirteen of 27 (48.1%) patients had height standard deviation scores (hSDS) <-2 at presentation, and 6 (22.2%) patients who had normal glomerular function were still below -2 SDS at the last examination. Hypercalciuria was present in 25 (92.6%) patients at the first evaluation and in 6 (22.2%) patients at the last examination. The degree of NC worsened in 6 (22.2%), remained stable in 15 (55.5%) and decreased in 6 (22.2%) patients during the followup period. Chronic renal insufficiency (CRI) developed in 5 patients without there being any increase in the degree of NC. In conclusion, growth and renal function in these patients generally depend on the nature of the underlying disease but not the degree of NC.


Subject(s)
Acidosis, Renal Tubular/complications , Nephrocalcinosis/etiology , Nephrocalcinosis/physiopathology , Bartter Syndrome/complications , Comorbidity , Glomerular Filtration Rate , Humans , Kidney/physiopathology , Nephrocalcinosis/epidemiology , Renal Insufficiency, Chronic/epidemiology , Retrospective Studies
19.
Pediatr Res ; 73(2): 194-200, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23174703

ABSTRACT

BACKGROUND: Nephrocalcinosis (NC) is an important clinical problem seen in critically ill preterm neonates treated with loop diuretics. No reliable animal models are available to study the pathogenesis of NC in preterm infants. The purpose of this study was to develop a reproducible and clinically relevant animal model of NC for these patients and to explore the impact of extracellular fluid (ECF) volume contraction induced by sodium and chloride depletion in this process. METHODS: Three-week-old weanling Sprague-Dawley rats were fed diets deficient in either chloride or sodium or both. A subgroup of rats from each dietary group was injected daily with furosemide (40 mg/kg i.p.). RESULTS: Rats fed a control diet, with or without furosemide, or a chloride-depleted diet alone, did not develop NC. By contrast, 50% of the rats injected with furosemide and fed the chloride-depleted diet developed NC. Moreover, 94% of the rats fed the combined sodium- and chloride-depleted diet developed NC, independently of furosemide use. NC was associated with the development of severe ECF volume contraction; hypochloremic, hypokalemic, metabolic alkalosis; increased phosphaturia; and growth retardation. CONCLUSION: Severe ECF volume contraction induced by chronic sodium and chloride depletion appears to play an important role in the pathogenesis of NC.


Subject(s)
Chlorides/metabolism , Kidney/metabolism , Nephrocalcinosis/etiology , Sodium Chloride, Dietary/metabolism , Sodium/deficiency , Water-Electrolyte Balance , Animals , Blood Pressure , Calcium/urine , Disease Models, Animal , Furosemide , Kidney/physiopathology , Male , Nephrocalcinosis/chemically induced , Nephrocalcinosis/metabolism , Nephrocalcinosis/physiopathology , Phosphorus/urine , Rats , Rats, Sprague-Dawley , Time Factors , Weight Gain
20.
Magnes Res ; 25(4): 149-58, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23261516

ABSTRACT

BACKGROUND: Hypomagnesemia is frequently encountered in hospitalized patients. The aim of this study was to determine the underlying causes of hypomagnesemia as well as the clinical and biochemical characteristics, and concomitant electrolyte and acid-base abnormalities in patients with decreased serum magnesium (Mg(2+)) levels in an internal medicine clinic. METHODS: We prospectively studied adult patients who, either on admission to our clinic or during their hospitalization, were found to have hypomagnesemia (serum Mg(2+) concentration <1.3 mEq/L). RESULTS: One hundred and seven patients out of 2284 patients had hypomagnesemia. The incidence of hypomagnesemia was 4.7%. Malnutrition, drugs (mainly diuretics and aminoglycosides), respiratory alkalosis, diabetes mellitus, acute tubular necrosis, alcohol consumption and gastrointestinal losses were the main causes of the hypomagnesemia. In the majority of patients (80%), more than one condition may have contributed to the development of hypomagnesemia. Seventy-one patients (66.3%) exhibited at least one additional electrolyte disorder. Hypophosphatemia was the most frequent electrolyte abnormality (31.1%), followed by hypokalemia (26.1%), hyponatremia (21.5%), and hypocalcemia (22%). Seventy-eight patients (72.9%) exhibited pure or mixed acid-base disorders, mainly respiratory alkalosis (20.6%), metabolic acidosis (15.8%), and mixed metabolic alkalosis and respiratory alkalosis (18.7%). CONCLUSIONS: Hypomagnesemia in patients hospitalized in an internal medicine clinic was of multifactorial origin. A wide array of concurrent acid-base and electrolyte disorders was evident in this population.


Subject(s)
Hospital Departments/trends , Hospitalization/trends , Hypercalciuria/diagnosis , Hypercalciuria/epidemiology , Internal Medicine/trends , Nephrocalcinosis/diagnosis , Nephrocalcinosis/epidemiology , Nutritional Status , Renal Tubular Transport, Inborn Errors/diagnosis , Renal Tubular Transport, Inborn Errors/epidemiology , Aged , Aged, 80 and over , Cohort Studies , Female , Humans , Hypercalciuria/physiopathology , Male , Middle Aged , Nephrocalcinosis/physiopathology , Nutritional Status/physiology , Prospective Studies , Renal Tubular Transport, Inborn Errors/physiopathology , Water-Electrolyte Imbalance/diagnosis , Water-Electrolyte Imbalance/epidemiology , Water-Electrolyte Imbalance/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL